Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Seretide

    - PMLiVE

    GSK to explore link between Shingrix and dementia risk in new UK research collaboration

    More than 55 million people worldwide are currently living with the neurodegenerative disease

    - PMLiVE

    Study reveals GSK’s new recombinant shingles vaccine could reduce dementia risk

    Shingrix reduced dementia diagnoses by 17% compared to Merck & Co’s Zostavax after six years

    - PMLiVE

    GSK’s shingles vaccine shown to maintain high protection in long-term study

    The infectious condition affects up to one in three people globally in their lifetimes

    - PMLiVE

    FDA approves Alvotech and Teva’s Simlandi as interchangeable Humira biosimilar

    Simlandi is approved to treat multiple indications, including rheumatoid arthritis and Crohn’s disease

    - PMLiVE

    Sandoz separates from Novartis as an independent spin-off company

    The split allows Sandoz to strengthen its position in generics and biosimilars

    - PMLiVE

    CureVac advances ‘promising’ seasonal flu mRNA vaccine to phase 2 development

    The mid-stage study of the candidate is expected to begin in the fourth quarter of 2023

    - PMLiVE

    NHS extends eligibility for shingles vaccine to almost one million people

    Approximately one in four people will develop shingles and the risk increases with age

    - PMLiVE

    Teva and Allergan finalise terms of US opioid settlements worth $6.6bn combined

    Nearly 500,000 died from an opioid overdose between 1999 and 2019

    - PMLiVE

    FDA approves GSK’s Priorix vaccine for measles, mumps and rubella

    The vaccine has been approved to use in those aged 12 months and above

    - PMLiVE

    Rare cancer specialists Sierra Oncology acquired by GSK for £1.5bn

    Unification will help to uphold and progress promising Momelotinib treatment which targets myelofibrosis

    - PMLiVE

    GSK and CureVac sign deal with Germany for mRNA COVID-19 vaccines

    The agreement is part of a Pandemic Preparedness Contract and means millions of vaccines can be produced at short notice during future public health emergencies

    - PMLiVE

    Sandoz launches generic oncology treatment in Europe

    Lenalidomide can be used to treat patients with haemato-onocology conditions, following recommendations from recent European Society for Medical Oncology (ESMO) guidelines

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links